However, though more than 40 PSP cases have been reported with AKT1 E17K mutation (13, 14), malignant progression has been rarely reported, which indicated that single E17K mutation on the PH domain of the AKT1 gene might not be sufficient to initiate the malignant transformation of the tumor. This evidence concerns the gene AKT1 and neoplasm.